GOLDMAN SACHS GROUP INC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 65 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$4,196
-38.2%
22,084
+10.5%
0.00%
Q1 2023$6,795
+5.2%
19,9840.0%0.00%
Q4 2022$6,461
-28.2%
19,984
-5.8%
0.00%
Q3 2022$9,000
-10.0%
21,222
-10.8%
0.00%
Q2 2022$10,000
-66.7%
23,782
-0.5%
0.00%
Q1 2022$30,000
-6.2%
23,905
-2.0%
0.00%
Q4 2021$32,000
-36.0%
24,382
+0.0%
0.00%
Q3 2021$50,000
-35.1%
24,381
-50.0%
0.00%
Q2 2021$77,000
+22.2%
48,736
+71.0%
0.00%
Q1 2021$63,0000.0%28,500
+11.9%
0.00%
Q4 2020$63,000
+8.6%
25,472
+7.9%
0.00%
Q3 2020$58,000
-32.6%
23,614
-2.6%
0.00%
Q2 2020$86,000
-77.2%
24,244
-84.9%
0.00%
Q1 2020$377,000
+314.3%
160,996
+290.0%
0.00%
Q4 2019$91,000
+54.2%
41,278
+27.5%
0.00%
Q3 2019$59,000
-74.2%
32,378
-79.5%
0.00%
Q2 2019$229,000
+99.1%
158,165
+170.0%
0.00%
Q1 2019$115,000
+101.8%
58,585
+34.8%
0.00%
Q4 2018$57,000
-54.0%
43,450
-13.9%
0.00%
Q3 2018$124,000
-14.5%
50,451
+16.8%
0.00%
Q2 2018$145,000
+168.5%
43,205
+240.1%
0.00%
Q1 2018$54,000
+1.9%
12,703
-8.8%
0.00%
Q3 2017$53,000
-54.7%
13,931
-47.7%
0.00%
Q2 2017$117,00026,6560.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2020
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$44,0000.03%
Brown Advisory Securities, LLC 28,000$35,0000.02%
Murchinson Ltd. 76,404$96,0000.02%
WEBSTER BANK, N. A. 80,000$101,0000.01%
Patriot Financial Group Insurance Agency, LLC 34,650$44,0000.01%
WMS Partners, LLC 42,000$53,0000.01%
Willow Creek Wealth Management Inc. 18,724$24,0000.01%
Cubic Asset Management, LLC 14,000$18,0000.00%
CVI Holdings, LLC 45,993$58,0000.00%
One Day In July LLC 10,000$13,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders